NOVEL METHODS Application WO-2023225620-A1 World Intellectual Property Organisation (WIPO) 23 Nov 2023
Transmucosal methods for treating psychiatric and neurological conditions Grant US-11806347-B2 United States of America 07 Nov 2023
Methods of treatment using pharmaceutical capsule compositions comprising lumateperone… Grant US-11806348-B2 United States of America 07 Nov 2023
4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quino… Grant US-11753419-B2 United States of America 12 Sep 2023
Pharmaceutical capsule compositions comprising lumateperone mono-tosylate Grant US-11690842-B2 United States of America 04 Jul 2023
Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro… Grant US-11680065-B2 United States of America 20 Jun 2023
Substituted heterocycle fused gamma-carbolines synthesis Grant US-11453670-B2 United States of America 27 Sep 2022
4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quino… Grant US-RE48825-E1 United States of America 23 Nov 2021
Transmucosal methods for treating psychiatric and neurological conditions Grant US-11052083-B2 United States of America 06 Jul 2021
Pharmaceutical capsule compositions comprising lumateperone mono-tosylate Grant US-11052084-B2 United States of America 06 Jul 2021
Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H… Grant US-11014925-B2 United States of America 25 May 2021
Methods of treating schizophrenia and depression Grant US-10960009-B2 United States of America 30 Mar 2021
Pharmaceutical compositions for sustained or delayed release Grant US-10960010-B2 United States of America 30 Mar 2021
Substituted heterocycle fused gamma-carbolines for treatment of central nervous system… Grant US-10961245-B2 United States of America 30 Mar 2021
Pharmaceutical compositions comprising 4-(6BR,10AS)-3-methyl-2,3,6B,9,10,10A-hexahydro-1h… Grant US-10844061-B2 United States of America 24 Nov 2020
METHODS OF TREATING NEUROPATHIC PAIN Application WO-2020206391-A1 World Intellectual Property Organisation (WIPO) 08 Oct 2020
Pharmaceutical capsule compositions comprising lumateperone mono-tosylate Grant US-10695345-B2 United States of America 30 Jun 2020
Method for the treatment of residual symptoms of schizophrenia Grant US-9956227-B2 United States of America 01 May 2018
DEUTERATED ITI-007 Application WO-2017117514-A1 World Intellectual Property Organisation (WIPO) 06 Jul 2017
4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de… Grant US-9586960-B2 United States of America 07 Mar 2017
4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quino… Grant US-9199995-B2 United States of America 01 Dec 2015